The Department of Biobehavioral Health, Pennsylvania State University, 219 Biobehavioral Health Building, University Park, PA, 16801, USA.
Department of Psychology, Temple University, Philadelphia, PA, USA.
Psychopharmacology (Berl). 2018 Apr;235(4):1211-1219. doi: 10.1007/s00213-018-4837-4. Epub 2018 Jan 30.
Numerous studies have attributed the psychopathology of post-traumatic stress disorder (PTSD) to maladaptive behavioral responses such as an inability to extinguish fear. While exposure therapies are mostly effective in treating these disorders by enhancing extinction learning, relapse of PTSD symptoms is common. Although several studies indicated a role for cholinergic transmission and nicotinic acetylcholine receptors (nAChRs) in anxiety and stress disorder symptomatology, very little is known about the specific contribution of nAChRs to fear extinction OBJECTIVES: In the present study, we examined the effects of inhibition and desensitization of α4β2 nAChRs via a full antagonist (Dihydro-beta-erythroidine (DhβE)) and two α4β2 nAChR partial-agonists (varenicline and sazetidine-A) on contextual fear extinction, locomotor activity, and spontaneous recovery of contextual fear in mice.
We trained and tested the subjects in a contextual fear extinction as well as an open field paradigm and spontaneous recovery following injections of DhβE, varenicline, and sazetidine-A.
Our results demonstrated that lower doses of DhβE (1 mg/kg) and sazetidine-A (0.01 mg/kg) enhanced contextual fear extinction whereas higher doses of varenicline (0.1 mg/kg) and sazetidine-A (0.1 mg/kg) resulted in impaired contextual fear extinction. However, the higher dose of sazetidine-A (0.1 mg/kg) decreased locomotor activity, which may contribute to increased freezing response observed during fear extinction. Finally, we found that the low dose of DhβE, but not sazetidine-A, also decreased spontaneous recovery of contextual fear following fear extinction.
Overall, these results suggest that inhibition and desensitization of α4β2 nAChRs enhance extinction of contextual fear memories. This suggests that modulation of α4β2 nAChRs may be employed as an alternative pharmacological strategy to aid exposure therapies associated with PTSD by augmenting contextual fear extinction processes.
许多研究将创伤后应激障碍(PTSD)的精神病理学归因于适应不良的行为反应,例如无法消除恐惧。虽然暴露疗法通过增强消退学习在治疗这些疾病方面大多非常有效,但 PTSD 症状的复发很常见。尽管有几项研究表明胆碱能传递和烟碱型乙酰胆碱受体(nAChRs)在焦虑和应激障碍症状学中起作用,但对于 nAChRs 对恐惧消退的具体贡献知之甚少。
在本研究中,我们通过完全拮抗剂(二氢-β-erythroidine(DhβE))和两种 α4β2 nAChR 部分激动剂(伐尼克兰和 sazetidine-A)检查了抑制和脱敏α4β2 nAChRs 对情境恐惧消退、运动活动和情境恐惧自发恢复的影响。
我们在情境恐惧消退以及开放式场范式和 DhβE、伐尼克兰和 sazetidine-A 注射后的自发恢复中对受试对象进行了训练和测试。
我们的结果表明,较低剂量的 DhβE(1mg/kg)和 sazetidine-A(0.01mg/kg)增强了情境恐惧消退,而较高剂量的伐尼克兰(0.1mg/kg)和 sazetidine-A(0.1mg/kg)导致情境恐惧消退受损。然而,较高剂量的 sazetidine-A(0.1mg/kg)降低了运动活动,这可能导致在恐惧消退过程中观察到的冻结反应增加。最后,我们发现低剂量的 DhβE,但不是 sazetidine-A,也降低了恐惧消退后的情境恐惧自发恢复。
总的来说,这些结果表明抑制和脱敏α4β2 nAChRs 增强了情境恐惧记忆的消退。这表明,调节 α4β2 nAChRs 可以作为一种替代的药理学策略,通过增强情境恐惧消退过程,辅助与 PTSD 相关的暴露疗法。